Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection
• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity.
Gespeichert in:
| Autor*in: |
Brebion, Amélie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management - Scheen, Marc ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:62 ; year:2015 ; pages:110-113 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jcv.2014.10.019 |
|---|
| Katalog-ID: |
ELV018214592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV018214592 | ||
| 003 | DE-627 | ||
| 005 | 20230623142515.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcv.2014.10.019 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015003000004.pica |
| 035 | |a (DE-627)ELV018214592 | ||
| 035 | |a (ELSEVIER)S1386-6532(14)00406-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 616.019405 |q OCLC |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Brebion, Amélie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| 264 | 1 | |c 2015 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. | ||
| 650 | 7 | |a Diagnosis |2 Elsevier | |
| 650 | 7 | |a Human rhinovirus |2 Elsevier | |
| 650 | 7 | |a Molecular assays |2 Elsevier | |
| 700 | 1 | |a Mirand, Audrey |4 oth | |
| 700 | 1 | |a Regagnon, Christel |4 oth | |
| 700 | 1 | |a Archimbaud, Christine |4 oth | |
| 700 | 1 | |a Chambon, Martine |4 oth | |
| 700 | 1 | |a Peigue-Lafeuille, Hélène |4 oth | |
| 700 | 1 | |a Henquell, Cécile |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Scheen, Marc ELSEVIER |t Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV007727844 |
| 773 | 1 | 8 | |g volume:62 |g year:2015 |g pages:110-113 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jcv.2014.10.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 62 |j 2015 |h 110-113 |g 4 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a b ab |
|---|---|
| matchkey_str |
brebionamliemirandaudreyregagnonchristel:2015----:vlainfelietcriovcgnborexivrin1n |
| hierarchy_sort_str |
2015 |
| bklnumber |
44.45 |
| publishDate |
2015 |
| allfields |
10.1016/j.jcv.2014.10.019 doi GBVA2015003000004.pica (DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Brebion, Amélie verfasserin aut Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection 2015 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier Mirand, Audrey oth Regagnon, Christel oth Archimbaud, Christine oth Chambon, Martine oth Peigue-Lafeuille, Hélène oth Henquell, Cécile oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:62 year:2015 pages:110-113 extent:4 https://doi.org/10.1016/j.jcv.2014.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 62 2015 110-113 4 045F 610 |
| spelling |
10.1016/j.jcv.2014.10.019 doi GBVA2015003000004.pica (DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Brebion, Amélie verfasserin aut Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection 2015 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier Mirand, Audrey oth Regagnon, Christel oth Archimbaud, Christine oth Chambon, Martine oth Peigue-Lafeuille, Hélène oth Henquell, Cécile oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:62 year:2015 pages:110-113 extent:4 https://doi.org/10.1016/j.jcv.2014.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 62 2015 110-113 4 045F 610 |
| allfields_unstemmed |
10.1016/j.jcv.2014.10.019 doi GBVA2015003000004.pica (DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Brebion, Amélie verfasserin aut Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection 2015 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier Mirand, Audrey oth Regagnon, Christel oth Archimbaud, Christine oth Chambon, Martine oth Peigue-Lafeuille, Hélène oth Henquell, Cécile oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:62 year:2015 pages:110-113 extent:4 https://doi.org/10.1016/j.jcv.2014.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 62 2015 110-113 4 045F 610 |
| allfieldsGer |
10.1016/j.jcv.2014.10.019 doi GBVA2015003000004.pica (DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Brebion, Amélie verfasserin aut Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection 2015 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier Mirand, Audrey oth Regagnon, Christel oth Archimbaud, Christine oth Chambon, Martine oth Peigue-Lafeuille, Hélène oth Henquell, Cécile oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:62 year:2015 pages:110-113 extent:4 https://doi.org/10.1016/j.jcv.2014.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 62 2015 110-113 4 045F 610 |
| allfieldsSound |
10.1016/j.jcv.2014.10.019 doi GBVA2015003000004.pica (DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Brebion, Amélie verfasserin aut Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection 2015 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier Mirand, Audrey oth Regagnon, Christel oth Archimbaud, Christine oth Chambon, Martine oth Peigue-Lafeuille, Hélène oth Henquell, Cécile oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:62 year:2015 pages:110-113 extent:4 https://doi.org/10.1016/j.jcv.2014.10.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 62 2015 110-113 4 045F 610 |
| language |
English |
| source |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:62 year:2015 pages:110-113 extent:4 |
| sourceStr |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:62 year:2015 pages:110-113 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
Diagnosis Human rhinovirus Molecular assays |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| authorswithroles_txt_mv |
Brebion, Amélie @@aut@@ Mirand, Audrey @@oth@@ Regagnon, Christel @@oth@@ Archimbaud, Christine @@oth@@ Chambon, Martine @@oth@@ Peigue-Lafeuille, Hélène @@oth@@ Henquell, Cécile @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007727844 |
| dewey-sort |
3610 |
| id |
ELV018214592 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018214592</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623142515.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2014.10.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018214592</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(14)00406-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brebion, Amélie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human rhinovirus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Molecular assays</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mirand, Audrey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Regagnon, Christel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Archimbaud, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chambon, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peigue-Lafeuille, Hélène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Henquell, Cécile</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:62</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:110-113</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2014.10.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">62</subfield><subfield code="j">2015</subfield><subfield code="h">110-113</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Brebion, Amélie |
| spellingShingle |
Brebion, Amélie ddc 610 ddc 616.019405 bkl 44.45 Elsevier Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| authorStr |
Brebion, Amélie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007727844 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 616 - Diseases |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays Elsevier |
| topic |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays |
| topic_unstemmed |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays |
| topic_browse |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier Diagnosis Elsevier Human rhinovirus Elsevier Molecular assays |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a m am c r cr c a ca m c mc h p l hpl c h ch |
| hierarchy_parent_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| hierarchy_parent_id |
ELV007727844 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007727844 |
| title |
Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| ctrlnum |
(DE-627)ELV018214592 (ELSEVIER)S1386-6532(14)00406-5 |
| title_full |
Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| author_sort |
Brebion, Amélie |
| journal |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| journalStr |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
110 |
| author_browse |
Brebion, Amélie |
| container_volume |
62 |
| physical |
4 |
| class |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Brebion, Amélie |
| doi_str_mv |
10.1016/j.jcv.2014.10.019 |
| dewey-full |
610 616.019405 |
| title_sort |
evaluation of real-time rt-pcr rhino&ev/cc r-gene® (biomérieux) kit versions 1 and 2 for rhinovirus detection |
| title_auth |
Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| abstract |
• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. |
| abstractGer |
• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. |
| abstract_unstemmed |
• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection |
| url |
https://doi.org/10.1016/j.jcv.2014.10.019 |
| remote_bool |
true |
| author2 |
Mirand, Audrey Regagnon, Christel Archimbaud, Christine Chambon, Martine Peigue-Lafeuille, Hélène Henquell, Cécile |
| author2Str |
Mirand, Audrey Regagnon, Christel Archimbaud, Christine Chambon, Martine Peigue-Lafeuille, Hélène Henquell, Cécile |
| ppnlink |
ELV007727844 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.jcv.2014.10.019 |
| up_date |
2024-07-06T18:17:22.560Z |
| _version_ |
1803854641952194560 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018214592</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623142515.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2014.10.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018214592</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(14)00406-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brebion, Amélie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene® (bioMérieux) kit versions 1 and 2 for rhinovirus detection</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Two versions of a commercial real-time RT-PCR assay were evaluated. • They were compared to an in-house conventional RT-PCR assay. • The first version detected 85% of HRV-A, 84% of HRV-B and 75% of HRV-C isolates. • The new version showed a slightly higher sensitivity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human rhinovirus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Molecular assays</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mirand, Audrey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Regagnon, Christel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Archimbaud, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chambon, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peigue-Lafeuille, Hélène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Henquell, Cécile</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:62</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:110-113</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2014.10.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">62</subfield><subfield code="j">2015</subfield><subfield code="h">110-113</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4011555 |